Global Non-Animal Alternative Testing Market Size study, By Technology (Cell Culture, High Throughput, Molecular Imaging, OMIC Technology) By Method (Cellular Assay, Biochemical Assay, In-silico, Ex-vivo), End User (Pharmaceutical Industry, Cosmetics & Ho

Global Non-Animal Alternative Testing Market Size study, By Technology (Cell Culture, High Throughput, Molecular Imaging, OMIC Technology) By Method (Cellular Assay, Biochemical Assay, In-silico, Ex-vivo), End User (Pharmaceutical Industry, Cosmetics & Household Products, Diagnostics, Chemicals Industry, Food Industry) and Regional Forecasts 2022-2028

Global Non-Animal Alternative Testing Market is valued approximately USD 9.8 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 13.50% over the forecast period 2022-2028. Non-Animal Alternative Testing is a testing procedure that does not utilize animals to establish safety requirements for products such as pharmaceuticals and cosmetics. Drugs and cosmetics are tested using non-animal alternatives some of the methodologies utilized include organs-on-chip, in-vitro testing, and in-silico testing. The rising prevalence of chronic diseases and increase in usage of organs-on-chip technology as well as Strategic initiatives from leading market players are key factors accelerating the growth of the Market. According to – National Health Council USA – as of 2020, around 40 million American citizens are limited in their usual activities due to one or more chronic health conditions. In addition, around 133 million U.S. citizens are affected by chronic diseases, representing more than 40% of the total population of the country. Moreover, authorities across the globe are approving non-animal testing methods, this factor would influence the growth of the market during the forecast period. For instance, in 2021, the Organisation for economic co-opertation and development approved their first overall testing strategy to predict skin allergic reactions without the application of animal testing. Also, increasing favorable initiatives from authorities to ban the usage of animals in drug testing and growing advancements in In-vitro testing would create lucrative opportunities for the Market during the forecast period. However, a lack of awareness impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Non-Animal Alternative Testing Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region due to factors such as the rising incidence of chronic diseases as well as the presence of leading market players in the region. Whereas the Asia-Pacific market is anticipated to be the fastest growing region due to the rising ban on using animals in pre-clinical testing. In addition, leading market players are now investing in the introduction of new products in the region to support the development of research facilities and activities. In the coming years, these factors are projected to fuel the market expansion for non-animal alternative testing.

Major market player included in this report are:
VITROCELL Systems GmbH
Evotec SE
Biovit
MB Research Laboratories
Emulate, Inc.
TARA Biosystems, Inc.
Bio-Rad Laboratories, Inc.
Abbott
Hurel Corporation
TissUse GmbH

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Technology:
Cell Culture
High Throughput
Molecular Imaging
OMIC Technology
By Method:
Cellular Assay
Biochemical Assay
In-silico
Ex-vivo
By End User:
Pharmaceutical Industry
Cosmetics & Household Products
Diagnostics
Chemicals Industry
Food Industry

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Non-Animal Alternative Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

VITROCELL Systems GmbH
Evotec SE
Biovit
MB Research Laboratories
Emulate, Inc.
TARA Biosystems, Inc.
Bio-Rad Laboratories, Inc.
Abbott
Hurel Corporation
TissUse GmbH

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.